Open original FDA record ↗Recall record
- FDA identifier
- Z-2173-2021
- Company in FDA record
- BAXTER HEALTHCARE CORPORATION
- FDA record creation date
- Aug 2, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Baxter Healthcare Corporation has identified that the AMIA Sharesource User Guide that is used with the AMIA Automated PD System cyclers incorrectly describes the function of the UF (Ultrafiltration) Limit setting as the ending criteria of the cyclers Extra Last Drain Mode. In some locations in the guide, it states that the UF volume achieved must exceed the programmed UF Limit before the cycler will end the Extra Last Drain, allowing the patient to end therapy or proceed to their last fill.
Source facts
- Action
- The firm notified its consignees by letter on 06/30/2021. The letter explained the issue with the instructions for use, specifically, That the AMIA Sharesource User Guide describes the function of the UF (ultrafiltration) Limit setting as the ending criteria of the cycler's Extra Last Drain Mode. Baxter will be sending a Follow-Up communication once the AMIA Sharesource User Guide has been updated on the portal.
- Initiated
- 2021-06-30
- Root cause
- Under Investigation by firm
- Terminated
- 2024-04-10
- Distribution
- Worldwide distribution - US Nationwide distribution and the country of Japan.
- Recall number
- Z-2173-2021
- Recall status
- Terminated
- CDRH record ID
- 188153
- FDA record created
- 2021-08-02
- Recall event number
- 88219